Baricitinib for lung injury after brain bleed
Treatments studied
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests a pill called baricitinib to see if it helps people recover from lung injury after a brain bleed. It is for patients who need a breathing machine due to ARDS that started within a week of the bleed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had a brain bleed (not from an injury) confirmed on a CT scan.
- You developed a serious lung problem (ARDS) within 7 days after the bleed.
- You are on a breathing machine or need one.
- You do not have a serious infection, lung disease, or kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medication called baricitinib can help patients whose platelet counts remain dangerously low after a bone marrow transplant, even after standard treatments. Platelets are blood cells that help stop bleeding, and this study aims to see if baricitinib can restore them.
This trial tests baricitinib, an oral medication, for people with intestinal Behçet's disease that hasn't improved with standard treatments. It aims to see if baricitinib can reduce symptoms and help heal gut ulcers.
This trial looks at how a severe brain bleed (subarachnoid hemorrhage) might affect lung function and hyaluronic acid buildup in the lungs. It aims to find better ways to protect breathing for patients in the intensive care unit.
This trial tests whether a special mouth rinse and preventive antibiotics can lower the risk of pneumonia after a brain bleed (intracerebral hemorrhage). If you've had a small bleed in the upper part of the brain and are at risk for pneumonia, this study may help.
This study tests whether a medication called baricitinib can help protect the lungs in people who have had a sudden bleed around the brain. Baricitinib works by calming inflammation, which might reduce lung injury after the bleeding.
This trial tests if baricitinib, an anti-inflammatory drug, can help people with bleeding in the brain from a head injury. It is for adults with moderate to severe traumatic brain injury who are not immediately having surgery.
Hear when a new Pulmonary Injury After Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.